Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0191120100250121792
Journal of Korean Medical Science
2010 Volume.25 No. 12 p.1792 ~ p.1797
Desmopressin is an Effective Treatment for Mixed Nocturia with Nocturnal Polyuria and Decreased Nocturnal Bladder Capacity
Lee Hye-Won

Choo Myung-Soo
Lee Jeong-Gu
Park Choal-Hee
Paick Jae-Seung
Lee Jeong-Zoo
Han Deok-Hyun
Park Won-Hee
Lee Kyu-Sung
Abstract
To investigate the efficacy and safety of desmopressin in patients with mixed nocturia, Patients aged ¡Ã18 yr with mixed nocturia (¡Ã2 voids/night and a nocturnal polyuria index [NPi] >33% and a nocturnal bladder capacity index [NBCi] >1) were recruited. The optimum dose of oral desmopressin was determined during a 3-week dose-titration period and the determined dose was maintained for 4 weeks. The efficacy was assessed by the frequency-volume charts and the sleep questionnaire. The primary endpoint was the proportion of patients with a 50% or greater reduction in the number of nocturnal voids (NV) compared with baseline. Among 103 patients enrolled, 94 (79 men and 15 women) were included in the analysis. The proportion of patients with a 50% or greater reduction in NV was 68 (72%). The mean number of NV decreased significantly (3.20 to 1.34) and the mean nocturnal urine volume, nocturia index, NPi, and NBCi decreased significantly. The mean duration of sleep until the first NV was prolonged from 118.4¡¾44.1 to 220.3¡¾90.7 min (P<0.001). The overall impression of patients about their quality of sleep improved. Adverse events occurred in 6 patients, including one asymptomatic hyponatremia. Desmopressin is an effective and well-tolerated treatment for mixed nocturia.
KEYWORD
Urinary Bladder, Deamino Arginine Vasopressin, Hyponatremia, Nocturia, Nocturnal Polyuria
FullTexts / Linksout information
  
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø